GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 295 filers reported holding GUARDANT HEALTH INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $818 | +132.4% | 27,601 | +83.7% | 0.01% | +125.0% |
| Q1 2023 | $352 | -47.0% | 15,027 | -38.4% | 0.00% | -50.0% |
| Q4 2022 | $664 | -100.0% | 24,409 | -62.9% | 0.01% | -81.8% |
| Q3 2022 | $3,545,000 | +110.3% | 65,855 | +57.5% | 0.04% | +144.4% |
| Q2 2022 | $1,686,000 | -17.4% | 41,802 | +35.7% | 0.02% | +20.0% |
| Q1 2022 | $2,040,000 | -70.8% | 30,801 | -55.9% | 0.02% | -60.5% |
| Q4 2021 | $6,989,000 | -21.0% | 69,880 | -1.3% | 0.04% | -9.5% |
| Q3 2021 | $8,849,000 | +9.7% | 70,784 | +9.0% | 0.04% | +10.5% |
| Q2 2021 | $8,068,000 | +763.8% | 64,963 | +961.8% | 0.04% | +660.0% |
| Q1 2021 | $934,000 | +147.1% | 6,118 | +108.5% | 0.01% | +150.0% |
| Q4 2020 | $378,000 | -57.7% | 2,934 | -63.3% | 0.00% | -66.7% |
| Q3 2020 | $894,000 | +11.2% | 7,998 | -19.3% | 0.01% | -14.3% |
| Q2 2020 | $804,000 | +275.7% | 9,912 | +222.8% | 0.01% | +250.0% |
| Q1 2020 | $214,000 | -58.4% | 3,071 | -53.3% | 0.00% | -60.0% |
| Q4 2019 | $514,000 | +1.4% | 6,576 | -17.2% | 0.01% | +25.0% |
| Q3 2019 | $507,000 | +369.4% | 7,944 | +463.4% | 0.00% | +300.0% |
| Q1 2019 | $108,000 | – | 1,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |